COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 2831: Articles 28301-28310  | Next

Evaluation of "stratify and shield" as a policy option for ending the COVID-19 lockdown in the UK
McKeigue, P. M., Colhoun, H. M.
10.1101/2020.04.25.20079913 — Posted: 2020-04-30
Searching the Sigmoid-type trend in Lock Down period covid19 data of India and its different states
MONDAL, S., Ghosh, S.
10.1101/2020.04.25.20079624 — Posted: 2020-04-30
Genetic structure of SARS-CoV-2 in Western Germany reflects clonal superspreading and multiple independent introduction events
Walker, A., Houwaart, T., Wienemann, T., Kohns Vasconcelos, M., Strelow, D., Senff, T., Hülse, L., Adams, O., Andree, M., Hauka, S., Feldt, T., Jensen, B.-E., Keitel, V., Kindgen-Milles, D., Timm, J., Pfeffer, K., Dilthey, A. T.
10.1101/2020.04.25.20079517 — Posted: 2020-04-30 Discussion: Onsite
A HEURISTIC MODEL FOR SPREAD OF COVID-19 INFECTION CASES IN INDIA
BHATTACHARJEE, B.
10.1101/2020.04.25.20079483 — Posted: 2020-04-30
Increased travel times to United States SARS-CoV-2 testing sites: a spatial modeling study
Rader, B., Astley, C. M., Sy, K. T. L., Sewalk, K., Hswen, Y., Brownstein, J. S., Kraemer, M. U. G.
10.1101/2020.04.25.20074419 — Posted: 2020-04-30
Informative Ranking of Stand Out Collections of Symptoms: A New Data-Driven Approach to Identify the Strong Warning Signs of COVID 19
AlMomani, A. A. R., Bollt, E. M.
10.1101/2020.04.25.20079905 — Posted: 2020-04-30
COVID-19 Control Strategies and Intervention Effects in Resource Limited Settings: A Modeling Study
Pandey, K. R., Subedee, A., Khanal, B., Koirala, B.
10.1101/2020.04.26.20079673 — Posted: 2020-04-30
Inequalities in COVID19 mortality related to ethnicity and socioeconomic deprivation
Rose, T. C., Mason, K., Pennington, A., McHale, P., Taylor-Robinson, D. C., Barr, B.
10.1101/2020.04.25.20079491 — Posted: 2020-04-30
Modelling of Systemic versus Pulmonary Chloroquine Exposure in Man for COVID-19 Dose Selection
Aljayyoussi, G., Rajoli, R., Pertinez, H., Pennington, S., Hong, W. D., O'Neill, P., Owen, A., Ward, S., Biagini, G.
10.1101/2020.04.24.20078741 — Posted: 2020-04-30
SUCCESSFUL MANUFACTURING OF CLINICAL-GRADE SARS-CoV-2 SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPY
Leung, W., Soh, T. G., Linn, Y. C., Low, J. G.-H., Loh, J., Chan, M., Chng, W. J., Koh, L. P., Poon, M. L.-M., Ng, K. P., Kuick, C. H., Tan, T. T., Tan, L. K., Seng, M. S.-f.
10.1101/2020.04.24.20077487 — Posted: 2020-04-30 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).